etx-lipdpeds-ch17-fig7

Figure 17-7 – Goiter reduction volume (%) at last follow-up of patients treated only with radioiodine (left bars) as compared with patients that received recombinant human TSH plus radioiodine (right bars). Note the significant and early volume reduction with radioiodine preceded by rh TSH (146)

Figure 17-7 – Goiter reduction volume (%) at last follow-up of patients treated only with radioiodine (left bars) as compared with patients that received recombinant human TSH plus radioiodine (right bars). Note the significant and early volume reduction with radioiodine preceded by rh TSH (146)

Figure 17-7 – Goiter reduction volume (%) at last follow-up of patients treated only with radioiodine (left bars) as compared with patients that received recombinant human TSH plus radioiodine (right bars). Note the significant and early volume reduction with radioiodine preceded by rh TSH (146)